Home Matchpoint Therapeutics

Matchpoint Therapeutics

In operation
Series B
Covalent Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Matchpoint Therapeutics is a biotechnology company harnessing the power of covalency to discover precision covalent drugs, transforming the treatment of immune diseases and other serious conditions.
Matchpoint Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2021
info@MatchpointTx.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Immune System Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs